139 related articles for article (PubMed ID: 27208178)
1. Nuclear localizations of phosphatidylinositol 5-phosphate 4-kinases α and β are dynamic and independently regulated during starvation-induced stress.
Droubi A; Bulley SJ; Clarke JH; Irvine RF
Biochem J; 2016 Jul; 473(14):2155-63. PubMed ID: 27208178
[TBL] [Abstract][Full Text] [Related]
2. In B cells, phosphatidylinositol 5-phosphate 4-kinase-α synthesizes PI(4,5)P2 to impact mTORC2 and Akt signaling.
Bulley SJ; Droubi A; Clarke JH; Anderson KE; Stephens LR; Hawkins PT; Irvine RF
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10571-6. PubMed ID: 27601656
[TBL] [Abstract][Full Text] [Related]
3. Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization.
Clarke JH; Irvine RF
Biochem J; 2013 Aug; 454(1):49-57. PubMed ID: 23758345
[TBL] [Abstract][Full Text] [Related]
4. Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.
Noch EK; Yim I; Milner TA; Cantley LC
J Comp Neurol; 2021 Feb; 529(2):434-449. PubMed ID: 32449185
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of PI5P4Kα/β disrupts cell energy metabolism and selectively kills p53-null tumor cells.
Chen S; Chandra Tjin C; Gao X; Xue Y; Jiao H; Zhang R; Wu M; He Z; Ellman J; Ha Y
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001596
[TBL] [Abstract][Full Text] [Related]
6. Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.
Emerling BM; Hurov JB; Poulogiannis G; Tsukazawa KS; Choo-Wing R; Wulf GM; Bell EL; Shim HS; Lamia KA; Rameh LE; Bellinger G; Sasaki AT; Asara JM; Yuan X; Bullock A; Denicola GM; Song J; Brown V; Signoretti S; Cantley LC
Cell; 2013 Nov; 155(4):844-57. PubMed ID: 24209622
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.
Ma G; Duan Y; Huang X; Qian CX; Chee Y; Mukai S; Cui J; Samad A; Matsubara JA; Kazlauskas A; D'Amore PA; Gu S; Lei H
Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3935-43. PubMed ID: 27472081
[TBL] [Abstract][Full Text] [Related]
8. Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors.
Sivakumaren SC; Shim H; Zhang T; Ferguson FM; Lundquist MR; Browne CM; Seo HS; Paddock MN; Manz TD; Jiang B; Hao MF; Krishnan P; Wang DG; Yang TJ; Kwiatkowski NP; Ficarro SB; Cunningham JM; Marto JA; Dhe-Paganon S; Cantley LC; Gray NS
Cell Chem Biol; 2020 May; 27(5):525-537.e6. PubMed ID: 32130941
[TBL] [Abstract][Full Text] [Related]
9. Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7.
Ciruela A; Hinchliffe KA; Divecha N; Irvine RF
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):587-91. PubMed ID: 10698683
[TBL] [Abstract][Full Text] [Related]
10. Genomic tagging of endogenous type IIbeta phosphatidylinositol 5-phosphate 4-kinase in DT40 cells reveals a nuclear localisation.
Richardson JP; Wang M; Clarke JH; Patel KJ; Irvine RF
Cell Signal; 2007 Jun; 19(6):1309-14. PubMed ID: 17303380
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 5 Phosphate (PI5P): From Behind the Scenes to the Front (Nuclear) Stage.
Poli A; Zaurito AE; Abdul-Hamid S; Fiume R; Faenza I; Divecha N
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035587
[TBL] [Abstract][Full Text] [Related]
12. Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor.
Willems HMG; Edwards S; Boffey HK; Chawner SJ; Green C; Romero T; Winpenny D; Skidmore J; Clarke JH; Andrews SP
RSC Med Chem; 2023 May; 14(5):934-946. PubMed ID: 37252102
[TBL] [Abstract][Full Text] [Related]
13. Exploring phosphatidylinositol 5-phosphate 4-kinase function.
Bulley SJ; Clarke JH; Droubi A; Giudici ML; Irvine RF
Adv Biol Regul; 2015 Jan; 57():193-202. PubMed ID: 25311266
[TBL] [Abstract][Full Text] [Related]
14. The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding site.
Clarke JH; Giudici ML; Burke JE; Williams RL; Maloney DJ; Marugan J; Irvine RF
Biochem J; 2015 Mar; 466(2):359-67. PubMed ID: 25495341
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system.
Shim H; Wu C; Ramsamooj S; Bosch KN; Chen Z; Emerling BM; Yun J; Liu H; Choo-Wing R; Yang Z; Wulf GM; Kuchroo VK; Cantley LC
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7596-601. PubMed ID: 27313209
[TBL] [Abstract][Full Text] [Related]
16. Type I phosphatidylinositol 4-phosphate 5-kinase homo- and heterodimerization determines its membrane localization and activity.
Lacalle RA; de Karam JC; Martínez-Muñoz L; Artetxe I; Peregil RM; Sot J; Rojas AM; Goñi FM; Mellado M; Mañes S
FASEB J; 2015 Jun; 29(6):2371-85. PubMed ID: 25713054
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.
Lundquist MR; Goncalves MD; Loughran RM; Possik E; Vijayaraghavan T; Yang A; Pauli C; Ravi A; Verma A; Yang Z; Johnson JL; Wong JCY; Ma Y; Hwang KS; Weinkove D; Divecha N; Asara JM; Elemento O; Rubin MA; Kimmelman AC; Pause A; Cantley LC; Emerling BM
Mol Cell; 2018 May; 70(3):531-544.e9. PubMed ID: 29727621
[TBL] [Abstract][Full Text] [Related]
18. Nucleocytoplasmic shuttling of human inositol phosphate multikinase is influenced by CK2 phosphorylation.
Meyer R; Nalaskowski MM; Ehm P; Schröder C; Naj X; Brehm MA; Mayr GW
Biol Chem; 2012 Mar; 393(3):149-60. PubMed ID: 22718630
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ), a lipid signalling enigma.
Giudici ML; Clarke JH; Irvine RF
Adv Biol Regul; 2016 May; 61():47-50. PubMed ID: 26710750
[TBL] [Abstract][Full Text] [Related]
20. Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode.
Boffey HK; Rooney TPC; Willems HMG; Edwards S; Green C; Howard T; Ogg D; Romero T; Scott DE; Winpenny D; Duce J; Skidmore J; Clarke JH; Andrews SP
J Med Chem; 2022 Feb; 65(4):3359-3370. PubMed ID: 35148092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
